The Journal of Nutrition, Health & Aging

, Volume 12, Issue 9, pp 608–621 | Cite as

Management of obesity in the elderly: Too much and too late?

  • R. L. Kennedy
  • U. Malabu
  • M. Kazi
  • V. Shahsidhar


Obesity Metabolic Syndrome Body Composition DHEA Orlistat 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kennedy RL, Chokkalingham K, Srinivasan R. Obesity in the elderly: who should we be treating, and why, and how? Current Opinion in Clinical Nutrition & Metabolic Care 2004;7(1):3–9.Google Scholar
  2. 2.
    McTigue KM, Hess R, Ziouras J. Obesity in older adults: a systematic review of the evidence for diagnosis and treatment. Obesity 2006;14(9):1485–97.PubMedGoogle Scholar
  3. 3.
    Arterburn DE, Crane PK, Sullivan SD. The coming epidemic of obesity in elderly Americans. Journal of the American Geriatrics Society 2004;52(11):1907–12.PubMedGoogle Scholar
  4. 4.
    Li C, Ford ES, McGuire LC, Mokdad AH. Increasing trends in waist circumference and abdominal obesity among US adults. Obesity 2007;15(1):216–24.PubMedGoogle Scholar
  5. 5.
    Flegal KM, Williamson DF, Pamuk ER, Rosenberg HM. Estimating deaths attributable to obesity in the United States. [see comment]. American Journal of Public Health 2004;94(9):1486–9.PubMedGoogle Scholar
  6. 6.
    Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. [see comment]. JAMA 2005;293(15):1861–7.PubMedGoogle Scholar
  7. 7.
    Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006;295(13):1549–55.PubMedGoogle Scholar
  8. 8.
    Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999–2002. Diabetes Care 2006;29(6):1263–8.PubMedGoogle Scholar
  9. 9.
    Arterburn DE, Maciejewski ML, Tsevat J. Impact of morbid obesity on medical expenditures in adults. International Journal of Obesity 2005;29(3):334–9.PubMedGoogle Scholar
  10. 10.
    Ajani UA, Lotufo PA, Gaziano JM, Lee IM, Spelsberg A, Buring JE, et al. Body mass index and mortality among US male physicians. Annals of Epidemiology 2004;14(10):731–9.PubMedGoogle Scholar
  11. 11.
    Nyholm M, Merlo J, Rastam L, Lindblad U. Overweight and all-cause mortality in a Swedish rural population: Skaraborg Hypertension and Diabetes Project. Scandinavian Journal of Public Health 2005;33(6):478–86.PubMedGoogle Scholar
  12. 12.
    Jee SH, Sull JW, Park J, Lee SY, Ohrr H, Guallar E, et al. Body mass index and mortality in Korean men and women. New England Journal of Medicine 2006;355(8):779–87.PubMedGoogle Scholar
  13. 13.
    Manini TM, Everhart JE, Patel KV, Schoeller DA, Colbert LH, Visser M, et al. Daily activity energy expenditure and mortality among older adults. [see comment]. JAMA 2006;296(2):171–9.PubMedGoogle Scholar
  14. 14.
    Janssen I, Mark AE. Elevated body mass index and mortality risk in the elderly. Obesity Reviews 2007;8(1):41–59.PubMedGoogle Scholar
  15. 15.
    He Y, Jiang B, Wang J, Feng K, Chang Q, Fan L, et al. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. Journal of the American College of Cardiology 2006;47(8):1588–94.PubMedGoogle Scholar
  16. 16.
    Maggi S, Noale M, Gallina P, Bianchi D, Marzari C, Limongi F, et al. Metabolic syndrome, diabetes, and cardiovascular disease in an elderly Caucasian cohort: the Italian Longitudinal Study on Aging. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2006;61(5):505–10.Google Scholar
  17. 17.
    Park HS, Kim SM, Lee JS, Lee J, Han JH, Yoon DK, et al. Prevalence and trends of metabolic syndrome in Korea: Korean National Health and Nutrition Survey 1998–2001. Diabetes, Obesity & Metabolism 2007;9(1):50–8.Google Scholar
  18. 18.
    Gause-Nilsson I, Gherman S, Kumar Dey D, Kennerfalk A, Steen B. Prevalence of metabolic syndrome in an elderly Swedish population. Acta Diabetologica 2006;43(4):120–6.PubMedGoogle Scholar
  19. 19.
    Kasai T, Miyauchi K, Kurata T, Ohta H, Okazaki S, Miyazaki T, et al. Prognostic value of the metabolic syndrome for long-term outcomes in patients undergoing percutaneous coronary intervention. Circulation Journal 2006;70(12):1531–7.PubMedGoogle Scholar
  20. 20.
    Cabrera MAS, Gebara OCE, Diament J, Nussbacher A, Rosano G, Wajngarten M. Metabolic syndrome, abdominal obesity, and cardiovascular risk in elderly women. International Journal of Cardiology 2007;114(2):224–9.PubMedGoogle Scholar
  21. 21.
    Milionis HJ, Rizos E, Goudevenos J, Seferiadis K, Mikhailidis DP, Elisaf MS. Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects. Stroke 2005;36(7):1372–6.PubMedGoogle Scholar
  22. 22.
    Golledge J, Leicht A, Crowther RG, Clancy P, Spinks WL, Quigley F. Association of obesity and metabolic syndrome with the severity and outcome of intermittent claudication. Journal of Vascular Surgery 2007;45(1):40–6.PubMedGoogle Scholar
  23. 23.
    Otiniano ME, Du XL, Maldonado MR, Ray L, Markides K. Effect of metabolic syndrome on heart attack and mortality in Mexican-American elderly persons: findings of 7-year follow-up from the Hispanic established population for the epidemiological study of the elderly. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2005;60(4):466–70.Google Scholar
  24. 24.
    Ravaglia G, Forti P, Maioli F, Bastagli L, Chiappelli M, Montesi F, et al. Metabolic Syndrome: prevalence and prediction of mortality in elderly individuals. Diabetes Care 2006;29(11):2471–6.PubMedGoogle Scholar
  25. 25.
    Lee JS, Kritchevsky SB, Tylavsky F, Harris T, Simonsick EM, Rubin SM, et al. Weight change, weight change intention, and the incidence of mobility limitation in well-functioning community-dwelling older adults. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2005;60(8):1007–12.Google Scholar
  26. 26.
    Bohannon RW, Brennan PJ, Pescatello LS, Marschke L, Hasson S, Murphy M. Adiposity of elderly women and its relationship with self-reported and observed physical performance. Journal of Geriatric Physical Therapy 2005;28(1):10–3.PubMedGoogle Scholar
  27. 27.
    Jensen GL. Obesity and functional decline: epidemiology and geriatric consequences. Clinics in Geriatric Medicine; 21(4):677–87.Google Scholar
  28. 28.
    Lebrun CEI, van der Schouw YT, de Jong FH, Grobbee DE, Lamberts SW. Fat mass rather than muscle strength is the major determinant of physical function and disability in postmenopausal women younger than 75 years of age. Menopause 2006;13(3):474–81.PubMedGoogle Scholar
  29. 29.
    Cankurtaran M, Halil M, Yavuz BB, Dagli N, Oyan B, Ariogul S. Prevalence and correlates of metabolic syndrome (MS) in older adults. Archives of Gerontology á Geriatrics 2006;42(1):35–45.Google Scholar
  30. 30.
    Ramsay SE, Whincup PH, Shaper AG, Wannamethee SG. The relations of body composition and adiposity measures to ill health and physical disability in elderly men. American Journal of Epidemiology 2006;164(5):459–69.PubMedGoogle Scholar
  31. 31.
    Lafortuna CL, Agosti F, Proietti M, Adorni F, Sartorio A. The combined effect of adiposity, fat distribution and age on cardiovascular risk factors and motor disability in a cohort of obese women (aged 18–83). Journal of Endocrinological Investigation 2006;29(10):905–12.PubMedGoogle Scholar
  32. 32.
    Okoro CA, Zhong Y, Ford ES, Balluz LS, Strine TW, Mokdad AH. Association between the metabolic syndrome and its components and gait speed among U.S. adults aged 50 years and older: a cross-sectional analysis. BMC Public Health 2006;6:282.PubMedGoogle Scholar
  33. 33.
    Blazer DG, Hybels CF, Fillenbaum GG. Metabolic syndrome predicts mobility decline in a community-based sample of older adults. Journal of the American Geriatrics Society 2006;54(3):502–6.PubMedGoogle Scholar
  34. 34.
    Roriz-Cruz M, Rosset I, Wada T, Sakagami T, Ishine M, Roriz-Filho JS, et al. Stroke-independent association between metabolic syndrome and functional dependence, depression, and low quality of life in elderly community-dwelling Brazilian people. Journal of the American Geriatrics Society 2007;55(3):374–82.PubMedGoogle Scholar
  35. 35.
    Arterburn DE, McDonell MB, Hedrick SC, Diehr P, Fihn SD. Association of body weight with condition-specific quality of life in male veterans. American Journal of Medicine 2004;117(10):738–46.PubMedGoogle Scholar
  36. 36.
    Lebrun CEI, van der Schouw YT, de Jong FH, Pols HAP, Grobbee DE, Lamberts SWJ. Relations between body composition, functional and hormonal parameters and quality of life in healthy postmenopausal women. Maturitas 2006;55(1):82–92.PubMedGoogle Scholar
  37. 37.
    Sach TH, Barton GR, Doherty M, Muir KR, Jenkinson C, Avery AJ. The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D. International Journal of Obesity 2007;31(1):189–96.PubMedGoogle Scholar
  38. 38.
    Huang IC, Frangakis C, Wu AW. The relationship of excess body weight and healthrelated quality of life: evidence from a population study in Taiwan. International Journal of Obesity 2006;30(8):1250–9.PubMedGoogle Scholar
  39. 39.
    Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. [see comment][erratum appears in JAMA. 2005 Jul 13;294(2):182]. JAMA 2005;293(15):1868–74.PubMedGoogle Scholar
  40. 40.
    Noale M, Maggi S, Marzari C, Limongi F, Gallina P, Bianchi D, et al. Components of the metabolic syndrome and incidence of diabetes in elderly Italians: the Italian Longitudinal Study on Aging. Atherosclerosis 2006;187(2):385–92.PubMedGoogle Scholar
  41. 41.
    Onat A, Hergenc G, Turkmen S, Yazici M, Sari I, Can G. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation. Metabolism: Clinical & Experimental 2006;55(4):445–52.Google Scholar
  42. 42.
    Wexler DJ, Grant RW, Wittenberg E, Bosch JL, Cagliero E, Delahanty L, et al. Correlates of health-related quality of life in type 2 diabetes. Diabetologia 2006;49(7):1489–97.PubMedGoogle Scholar
  43. 43.
    Wray LA, Ofstedal MB, Langa KM, Blaum CS. The effect of diabetes on disability in middle-aged and older adults. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2005;60(9):1206–11.Google Scholar
  44. 44.
    Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. New England Journal of Medicine 2003;348(17):1625–38.PubMedGoogle Scholar
  45. 45.
    Sedjo RL, Byers T, Levin TR, Haffner SM, Saad MF, Tooze JA, et al. Change in body size and the risk of colorectal adenomas. Cancer Epidemiology, Biomarkers á Prevention 2007;16(3):526–31.Google Scholar
  46. 46.
    Sturmer T, Buring JE, Lee IM, Gaziano JM, Glynn RJ. Metabolic abnormalities and risk for colorectal cancer in the physicians’ health study. Cancer Epidemiology, Biomarkers & Prevention 2006;15(12):2391–7.Google Scholar
  47. 47.
    Janssen I. Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study. Journal of the American Geriatrics Society 2006;54(1):56–62.PubMedGoogle Scholar
  48. 48.
    Jinks C, Jordan K, Croft P. Disabling knee pain—another consequence of obesity: results from a prospective cohort study. BMC Public Health 2006;6:258.PubMedGoogle Scholar
  49. 49.
    Reijman M, Pols HAP, Bergink AP, Hazes JMW, Belo JN, Lievense AM, et al. Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam Study. [see comment]. Annals of the Rheumatic Diseases 2007;66(2):158–62.PubMedGoogle Scholar
  50. 50.
    Wannamethee SG, Shaper AG, Whincup PH. Body fat distribution, body composition, and respiratory function in elderly men. American Journal of Clinical Nutrition 2005;82(5):996–1003.PubMedGoogle Scholar
  51. 51.
    Yende S, Waterer GW, Tolley EA, Newman AB, Bauer DC, Taaffe DR, et al. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. [see comment]. Thorax 2006;61(1):10–6.PubMedGoogle Scholar
  52. 52.
    Ocasio-Tascon ME, Alicea-Colon E, Torres-Palacios A, Rodriguez-Cintron W. The veteran population: one at high risk for sleep-disordered breathing. Sleep á Breathing 2006;10(2):70–5.Google Scholar
  53. 53.
    Jackson RA, Vittinghoff E, Kanaya AM, Miles TP, Resnick HE, Kritchevsky SB, et al. Urinary incontinence in elderly women: findings from the Health, Aging, and Body Composition Study. Obstetrics & Gynecology 2004;104(2):301–7.Google Scholar
  54. 54.
    Asplund R. Obesity in elderly people with nocturia: cause or consequence? Canadian Journal of Urology 2007;14(1):3424–8.PubMedGoogle Scholar
  55. 55.
    Rey E, Moreno-Elola-Olaso C, Artalejo FR, Locke GR, 3rd, Diaz-Rubio M. Association between weight gain and symptoms of gastroesophageal reflux in the general population. American Journal of Gastroenterology 2006;101(2):229–33.PubMedGoogle Scholar
  56. 56.
    Oh S-Y, Cho Y-K, Kang M-S, Yoo T-W, Park J-H, Kim H-J, et al. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism: Clinical & Experimental 2006;55(12):1604–9.Google Scholar
  57. 57.
    Onat A, Hergenc G, Karabulut A, Turkmen S, Doan Y, Uyarel H, et al. Serum gamma glutamyltransferase as a marker of metabolic syndrome and coronary disease likelihood in nondiabetic middle-aged and elderly adults. Preventive Medicine 2006;43(2):136–9.PubMedGoogle Scholar
  58. 58.
    Clark JM. Weight loss as a treatment for nonalcoholic fatty liver disease. Journal of Clinical Gastroenterology 2006;40(3 Suppl 1):S39–43.PubMedGoogle Scholar
  59. 59.
    Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Archives of Ophthalmology 2003;121(6):785–92.PubMedGoogle Scholar
  60. 60.
    Moeini HA, Masoudpour H, Ghanbari H. A study of the relation between body mass index and the incidence of age related macular degeneration. British Journal of Ophthalmology 2005;89(8):964–6.PubMedGoogle Scholar
  61. 61.
    Klein R, Deng Y, Klein BEK, Hyman L, Seddon J, Frank RN, et al. Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women’s Health Initiative Sight Exam ancillary study. American Journal of Ophthalmology 2007;143(3):473–83.PubMedGoogle Scholar
  62. 62.
    Seddon JM, George S, Rosner B, Klein ML. CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Human Heredity 2006;61(3):157–65.PubMedGoogle Scholar
  63. 63.
    Schaumberg DA, Hankinson SE, Guo Q, Rimm E, Hunter DJ. A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. [see comment]. Archives of Ophthalmology 2007;125(1):55–62.PubMedGoogle Scholar
  64. 64.
    Seddon JM, George S, Rosner B, Rifai N. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Archives of Ophthalmology 2005;123(6):774–82.PubMedGoogle Scholar
  65. 65.
    Navarro Esteban JJ, Gutierrez Leiva JA, Valero Caracena N, Buendia Bermejo J, Calle Puron ME, Martinez Vizcaino VJ. Prevalence and risk factors of lens opacities in the elderly in Cuenca, Spain. European Journal of Ophthalmology 2007;17(1):29–37.PubMedGoogle Scholar
  66. 66.
    Vanhanen M, Koivisto K, Moilanen L, Helkala EL, Hanninen T, Soininen H, et al. Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology 2006;67(5):843–7.PubMedGoogle Scholar
  67. 67.
    Komulainen P, Lakka TA, Kivipelto M, Hassinen M, Helkala E-L, Haapala I, et al. Metabolic syndrome and cognitive function: a population-based follow-up study in elderly women. Dementia & Geriatric Cognitive Disorders 2007;23(1):29–34.Google Scholar
  68. 68.
    Xiong GL, Plassman BL, Helms MJ, Steffens DC. Vascular risk factors and cognitive decline among elderly male twins. Neurology 2006;67(9):1586–91.PubMedGoogle Scholar
  69. 69.
    McGuire LC, Ford ES, Ajani UA. Cognitive functioning as a predictor of functional disability in later life. American Journal of Geriatric Psychiatry 2006;14(1):36–42.PubMedGoogle Scholar
  70. 70.
    Rosano C, Simonsick EM, Harris TB, Kritchevsky SB, Brach J, Visser M, et al. Association between physical and cognitive function in healthy elderly: the health, aging and body composition study. Neuroepidemiology 2005;24(1–2):8–14.PubMedGoogle Scholar
  71. 71.
    Gorospe EC, Dave JK. The risk of dementia with increased body mass index. Age á Ageing 2007;36(1):23–9.Google Scholar
  72. 72.
    Alexandersen P, Tanko LB, Bagger YZ, Jespersen J, Skouby SO, Christiansen C. Associations between aortic calcification and components of body composition in elderly men. Obesity 2006;14(9):1571–8.PubMedGoogle Scholar
  73. 73.
    Blaum CS, Xue QL, Michelon E, Semba RD, Fried LP. The association between obesity and the frailty syndrome in older women: the Women’s Health and Aging Studies. [see comment]. Journal of the American Geriatrics Society 2005;53(6):927–34.PubMedGoogle Scholar
  74. 74.
    Woods NF, LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, Brunner RL, et al. Frailty: emergence and consequences in women aged 65 and older in the Women’s Health Initiative Observational Study. [see comment]. Journal of the American Geriatrics Society 2005;53(8):1321–30.PubMedGoogle Scholar
  75. 75.
    Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obesity Research 2004;12(12):1995–2004.PubMedGoogle Scholar
  76. 76.
    Cesari M, Leeuwenburgh C, Lauretani F, Onder G, Bandinelli S, Maraldi C, et al. Frailty syndrome and skeletal muscle: results from the Invecchiare in Chianti study. American Journal of Clinical Nutrition 2006;83(5):1142–8.PubMedGoogle Scholar
  77. 77.
    Liu-Ambrose T, Kravetsky L, Bailey D, Sherar L, Mundt C, Baxter-Jones A, et al. Change in lean body mass is a major determinant of change in areal bone mineral density of the proximal femur: a 12-year observational study. Calcified Tissue International 2006;79(3):145–51.PubMedGoogle Scholar
  78. 78.
    Aubertin-Leheudre M, Lord C, Goulet EDB, Khalil A, Dionne IJ. Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women. Obesity 2006;14(12):2277–83.PubMedGoogle Scholar
  79. 79.
    Katsiaras A, Newman AB, Kriska A, Brach J, Krishnaswami S, Feingold E, et al. Skeletal muscle fatigue, strength, and quality in the elderly: the Health ABC Study. Journal of Applied Physiology 2005;99(1):210–6.PubMedGoogle Scholar
  80. 80.
    Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2006;61(10):1059–64.Google Scholar
  81. 81.
    Kwan M, Woo J, Kwok T. The standard oxygen consumption value equivalent to one metabolic equivalent (3.5 ml/min/kg) is not appropriate for elderly people. International Journal of Food Sciences & Nutrition 2004;55(3):179–82.Google Scholar
  82. 82.
    Krems C, Luhrmann PM, Strassburg A, Hartmann B, Neuhauser-Berthold M. Lower resting metabolic rate in the elderly may not be entirely due to changes in body composition. European Journal of Clinical Nutrition 2005;59(2):255–62.PubMedGoogle Scholar
  83. 83.
    Tyagi R, Kapoor S, Kapoor AK. Body composition and fat distribution pattern of urban elderly females, Delhi, India. Collegium Antropologicum 2005;29(2):493–8.PubMedGoogle Scholar
  84. 84.
    Tanko LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C. Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. [see comment]. Circulation 2003;107(12):1626–31.PubMedGoogle Scholar
  85. 85.
    Ding J, Kritchevsky SB, Newman AB, Taaffe DR, Nicklas BJ, Visser M, et al. Effects of birth cohort and age on body composition in a sample of community-based elderly. American Journal of Clinical Nutrition 2007;85(2):405–10.PubMedGoogle Scholar
  86. 86.
    Sanchez-Garcia S, Garcia-Pena C, Duque-Lopez MX, Juarez-Cedillo T, Cortes-Nunez AR, Reyes-Beaman S. Anthropometric measures and nutritional status in a healthy elderly population. BMC Public Health 2007;7:2.PubMedGoogle Scholar
  87. 87.
    Goodpaster BH, Brown NF. Skeletal muscle lipid and its association with insulin resistance: what is the role for exercise? Exercise & Sport Sciences Reviews 2005;33(3):150–4.Google Scholar
  88. 88.
    Zamboni M, Zoico E, Fantin F, Panourgia MP, Di Francesco V, Tosoni P, et al. Relation between leptin and the metabolic syndrome in elderly women. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2004;59(4):396–400.Google Scholar
  89. 89.
    Crabbe P, Goemaere S, Zmierczak H, Van Pottelbergh I, De Bacquer D, Kaufman JM. Are serum leptin and the Gln223Arg polymorphism of the leptin receptor determinants of bone homeostasis in elderly men? European Journal of Endocrinology 2006;154(5):707–14.PubMedGoogle Scholar
  90. 90.
    Norata GD, Ongari M, Garlaschelli K, Raselli S, Grigore L, Catapano AL. Plasma resistin levels correlate with determinants of the metabolic syndrome. European Journal of Endocrinology 2007;156(2):279–84.PubMedGoogle Scholar
  91. 91.
    Schutte AE, Huisman HW, Schutte R, van Rooyen JM, Malan L, Malan NT. Aging influences the level and functions of fasting plasma ghrelin levels: the POWIRS-Study. Regulatory Peptides 2007;139(1–3):65–71.PubMedGoogle Scholar
  92. 92.
    Zoico E, Di Francesco V, Mazzali G, Vettor R, Fantin F, Bissoli L, et al. Adipocytokines, fat distribution, and insulin resistance in elderly men and women. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2004;59(9):M935–9.Google Scholar
  93. 93.
    Gannage-Yared M-H, Khalife S, Semaan M, Fares F, Jambart S, Halaby G. Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. European Journal of Endocrinology 2006;155(1):167–76.PubMedGoogle Scholar
  94. 94.
    Bik W, Baranowska-Bik A, Wolinska-Witort E, Martynska L, Chmielowska M, Szybinska A, et al. The relationship between adiponectin levels and metabolic status in centenarian, early elderly, young and obese women. Neuroendocrinology Letters 2006;27(4):493–500.PubMedGoogle Scholar
  95. 95.
    Frystyk J, Berne C, Berglund L, Jensevik K, Flyvbjerg A, Zethelius B. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. Journal of Clinical Endocrinology & Metabolism 2007;92(2):571–6.Google Scholar
  96. 96.
    Laughlin GA, Barrett-Connor E, May S, Langenberg C. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. American Journal of Epidemiology 2007;165(2):164–74.PubMedGoogle Scholar
  97. 97.
    Fatouros IG, Tournis S, Leontsini D, Jamurtas AZ, Sxina M, Thomakos P, et al. Leptin and adiponectin responses in overweight inactive elderly following resistance training and detraining are intensity related. Journal of Clinical Endocrinology á Metabolism 2005;90(11):5970–7.Google Scholar
  98. 98.
    Schrager MA, Metter EJ, Simonsick E, Ble A, Bandinelli S, Lauretani F, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. Journal of Applied Physiology 2007;102(3):919–25.PubMedGoogle Scholar
  99. 99.
    Hoekstra T, Geleijnse JM, Schouten EG, Kok FJ, Kluft C. Relationship of C-reactive protein with components of the metabolic syndrome in normal-weight and overweight elderly. Nutrition Metabolism & Cardiovascular Diseases 2005;15(4):270–8.Google Scholar
  100. 100.
    Figaro MK, Kritchevsky SB, Resnick HE, Shorr RI, Butler J, Shintani A, et al. Diabetes, inflammation, and functional decline in older adults: findings from the Health, Aging and Body Composition (ABC) study. Diabetes Care 2006;29(9):2039–45.PubMedGoogle Scholar
  101. 101.
    Penninx BWJH, Kritchevsky SB, Newman AB, Nicklas BJ, Simonsick EM, Rubin S, et al. Inflammatory markers and incident mobility limitation in the elderly. Journal of the American Geriatrics Society 2004;52(7):1105–13.PubMedGoogle Scholar
  102. 102.
    Jenny NS, Yanez ND, Psaty BM, Kuller LH, Hirsch CH, Tracy RP. Inflammation biomarkers and near-term death in older men. American Journal of Epidemiology 2007;165(6):684–95.PubMedGoogle Scholar
  103. 103.
    Sipila S. Body composition and muscle performance during menopause and hormone replacement therapy. Journal of Endocrinological Investigation 2003;26(9):893–901.PubMedGoogle Scholar
  104. 104.
    Augoulea A, Mastorakos G, Lambrinoudaki I, Christodoulakos G, Creatsas G. Role of postmenopausal hormone replacement therapy on body fat gain and leptin levels. Gynecological Endocrinology 2005;20(4):227–35.PubMedGoogle Scholar
  105. 105.
    Sowers M, Zheng H, Tomey K, Karvonen-Gutierrez C, Jannausch M, Li X, et al. Changes in body composition in women over six years at midlife: ovarian and chronological aging. Journal of Clinical Endocrinology & Metabolism 2007;92(3):895–901.Google Scholar
  106. 106.
    Tufano A, Marzo P, Enrini R, Morricone L, Caviezel F, Ambrosi B. Anthropometric, hormonal and biochemical differences in lean and obese women before and after menopause. Journal of Endocrinological Investigation 2004;27(7):648–53.PubMedGoogle Scholar
  107. 107.
    Morita Y, Iwamoto I, Mizuma N, Kuwahata T, Matsuo T, Yoshinaga M, et al. Precedence of the shift of body-fat distribution over the change in body composition after menopause. Journal of Obstetrics & Gynaecology Research 2006;32(5):513–6.Google Scholar
  108. 108.
    Li S, Wagner R, Holm K, Lehotsky J, Zinaman MJ. Relationship between soft tissue body composition and bone mass in perimenopausal women. Maturitas 2004;47(2):99–105.PubMedGoogle Scholar
  109. 109.
    Bagger YZ, Tanko LB, Alexandersen P, Qin G, Christiansen C. The implications of body fat mass and fat distribution for cognitive function in elderly women. Obesity Research 2004;12(9):1519–26.PubMedGoogle Scholar
  110. 110.
    Yannakoulia M, Melistas L, Solomou E, Yiannakouris N. Association of eating frequency with body fatness in pre- and postmenopausal women. Obesity 2007;15(1):100–6.PubMedGoogle Scholar
  111. 111.
    Chen Z, Bassford T, Green SB, Cauley JA, Jackson RD, LaCroix AZ, et al. Postmenopausal hormone therapy and body composition—a substudy of the estrogen plus progestin trial of the Women’s Health Initiative. American Journal of Clinical Nutrition 2005;82(3):651–6.PubMedGoogle Scholar
  112. 112.
    Maddalozzo GF, Cardinal BJ, Li F, Snow CM. The association between hormone therapy use and changes in strength and body composition in early postmenopausal women. Menopause 2004;11(4):438–46.PubMedGoogle Scholar
  113. 113.
    Sites CK, L’Hommedieu GD, Toth MJ, Brochu M, Cooper BC, Fairhurst PA. The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebocontrolled trial. Journal of Clinical Endocrinology & Metabolism 2005;90(5):2701–7.Google Scholar
  114. 114.
    Goodrow GJ, L’Hommedieu GD, Gannon B, Sites CK. Predictors of worsening insulin sensitivity in postmenopausal women. American Journal of Obstetrics & Gynecology 2006;194(2):355–61.Google Scholar
  115. 115.
    Allan CA, Strauss BJ, Burger HG, Forbes EA, McLachlan RI. The association between obesity and the diagnosis of androgen deficiency in symptomatic ageing men. Medical Journal of Australia 2006;185(8):424–7.PubMedGoogle Scholar
  116. 116.
    Travison TG, Araujo AB, O’Donnell AB, Kupelian V, McKinlay JB. A populationlevel decline in serum testosterone levels in American men. [see comment]. Journal of Clinical Endocrinology & Metabolism 2007;92(1):196–202.Google Scholar
  117. 117.
    Derby CA, Zilber S, Brambilla D, Morales KH, McKinlay JB. Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study. Clinical Endocrinology 2006;65(1):125–31.PubMedGoogle Scholar
  118. 118.
    Chen RYT, Wittert GA, Andrews GR. Relative androgen deficiency in relation to obesity and metabolic status in older men. Diabetes, Obesity & Metabolism 2006;8(4):429–35.Google Scholar
  119. 119.
    Maggio M, Lauretani F, Ceda GP, Bandinelli S, Basaria S, Ble A, et al. Association between hormones and metabolic syndrome in older Italian men. Journal of the American Geriatrics Society 2006;54(12):1832–8.PubMedGoogle Scholar
  120. 120.
    Laughlin GA, Barrett-Connor E, May S. Sex-specific association of the androgen to oestrogen ratio with adipocytokine levels in older adults: the Rancho Bernardo Study. Clinical Endocrinology 2006;65(4):506–13.PubMedGoogle Scholar
  121. 121.
    Carraro R, Ruiz-Torres A. Relationship of serum leptin concentration with age, gender, and biomedical parameters in healthy, non-obese subjects. Archives of Gerontology & Geriatrics 2006;43(3):301–12.Google Scholar
  122. 122.
    Zamboni M, Zoico E, Scartezzini T, Mazzali G, Tosoni P, Zivelonghi A, et al. Body composition changes in stable-weight elderly subjects: the effect of sex. Aging- Clinical & Experimental Research 2003;15(4):321–7.Google Scholar
  123. 123.
    Muller M, Grobbee DE, den Tonkelaar I, Lamberts SWJ, van der Schouw YT. Endogenous sex hormones and metabolic syndrome in aging men. [see comment]. Journal of Clinical Endocrinology & Metabolism 2005;90(5):2618–23.Google Scholar
  124. 124.
    Cappola AR, Ratcliffe SJ, Bhasin S, Blackman MR, Cauley J, Robbins J, et al. Determinants of serum total and free testosterone levels in women over the age of 65 years. Journal of Clinical Endocrinology & Metabolism 2007;92(2):509–16.Google Scholar
  125. 125.
    Santoro N, Torrens J, Crawford S, Allsworth JE, Finkelstein JS, Gold EB, et al. Correlates of circulating androgens in mid-life women: the study of women’s health across the nation.[see comment]. Journal of Clinical Endocrinology & Metabolism 2005;90(8):4836–45.Google Scholar
  126. 126.
    McTiernan A, Wu L, Chen C, Chlebowski R, Mossavar-Rahmani Y, Modugno F, et al. Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity 2006;14(9):1662–77.PubMedGoogle Scholar
  127. 127.
    Maggio M, Lauretani F, Ceda GP, Bandinelli S, Basaria S, Paolisso G, et al. Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study. American Journal of Physiology - Endocrinology á Metabolism 2007;292(1):E353–8.Google Scholar
  128. 128.
    Gould DC, Kirby RS, Amoroso P. Hypoandrogen-metabolic syndrome: a potentially common and underdiagnosed condition in men. International Journal of Clinical Practice 2007;61(2):341–4.PubMedGoogle Scholar
  129. 129.
    Nair KS, Rizza RA, O’Brien P, Dhatariya K, Short KR, Nehra A, et al. DHEA in elderly women and DHEA or testosterone in elderly men. [see comment]. New England Journal of Medicine 2006;355(16):1647–59.PubMedGoogle Scholar
  130. 130.
    Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocrine Reviews 2005;26(6):833–76.PubMedGoogle Scholar
  131. 131.
    Lapauw B, Goemaere S, Crabbe P, Kaufman JM, Ruige JB. Is the effect of testosterone on body composition modulated by the androgen receptor gene CAG repeat polymorphism in elderly men? European Journal of Endocrinology 2007;156(3):395–401.PubMedGoogle Scholar
  132. 132.
    Katznelson L, Robinson MW, Coyle CL, Lee H, Farrell CE. Effects of modest testosterone supplementation and exercise for 12 weeks on body composition and quality of life in elderly men. European Journal of Endocrinology 2006;155(6):867–75.PubMedGoogle Scholar
  133. 133.
    Huang X, Blackman MR, Herreman K, Pabst KM, Harman SM, Caballero B. Effects of growth hormone and/or sex steroid administration on whole-body protein turnover in healthy aged women and men. Metabolism: Clinical & Experimental 2005;54(9):1162–7.Google Scholar
  134. 134.
    Giannoulis MG, Jackson N, Shojaee-Moradie F, Sonksen PH, Martin FC, Umpleby AM. Effects of growth hormone and/or testosterone on very low density lipoprotein apolipoprotein B100 kinetics and plasma lipids in healthy elderly men: a randomised controlled trial. Growth Hormone & Igf Research 2006;16(5–6):308–17.Google Scholar
  135. 135.
    Villareal DT, Holloszy JO. DHEA enhances effects of weight training on muscle mass and strength in elderly women and men. American Journal of Physiology — Endocrinology & Metabolism 2006;291(5):E1003–8.Google Scholar
  136. 136.
    Leng SX, Cappola AR, Andersen RE, Blackman MR, Koenig K, Blair M, et al. Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging-Clinical & Experimental Research 2004;16(2):153–7.Google Scholar
  137. 137.
    Basu R, Man CD, Campioni M, Basu A, Nair KS, Jensen MD, et al. Two years of treatment with dehydroepiandrosterone does not improve insulin secretion, insulin action, or postprandial glucose turnover in elderly men or women. Diabetes 2007;56(3):753–66.PubMedGoogle Scholar
  138. 138.
    Kalme T, Seppala M, Qiao Q, Koistinen R, Nissinen A, Harrela M, et al. Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men. Journal of Clinical Endocrinology & Metabolism 2005;90(3):1550–6.Google Scholar
  139. 139.
    Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. Journal of Clinical Endocrinology & Metabolism 2006;91(3):843–50.Google Scholar
  140. 140.
    Cikim AS, Ozbey N, Sencer E, Molvalilar S, Orhan Y. Associations among sex hormone binding globulin concentrations and characteristics of the metabolic syndrome in obese women. Diabetes, Nutrition & Metabolism - Clinical á Experimental 2004;17(5):290–5.Google Scholar
  141. 141.
    Chen M-J, Yang W-S, Yang J-H, Hsiao CK, Yang Y-S, Ho H-N. Low sex hormonebinding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS. Human Reproduction 2006;21(9):2266–71.PubMedGoogle Scholar
  142. 142.
    Weinberg ME, Manson JE, Buring JE, Cook NR, Seely EW, Ridker PM, et al. Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women. Metabolism: Clinical & Experimental 2006;55(11):1473–80.Google Scholar
  143. 143.
    Heald AH, Anderson SG, Ivison F, Riste L, Laing I, Cruickshank JK, et al. Low sex hormone binding globulin is a potential marker for the metabolic syndrome in different ethnic groups. Experimental & Clinical Endocrinology & Diabetes 2005;113(9):522–8.Google Scholar
  144. 144.
    Sutton-Tyrrell K, Wildman RP, Matthews KA, Chae C, Lasley BL, Brockwell S, et al. Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 2005;111(10):1242–9.PubMedGoogle Scholar
  145. 145.
    Xita N, Tsatsoulis A, Chatzikyriakidou A, Georgiou I. Association of the (TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG serum levels. Journal of Clinical Endocrinology & Metabolism 2003;88(12):5976–80.Google Scholar
  146. 146.
    Mousavinasab F, Tahtinen T, Jokelainen J, Koskela P, Vanhala M, Oikarinen J, et al. The Pro12Ala polymorphism of the PPAR gamma 2 gene influences sex hormonebinding globulin level and its relationship to the development of the metabolic syndrome in young Finnish men. Endocrine 2006;30(2):185–90.PubMedGoogle Scholar
  147. 147.
    Toogood AA. The somatopause: an indication for growth hormone therapy? Treatments in Endocrinology 2004;3(4):201–9.PubMedGoogle Scholar
  148. 148.
    Lombardi G, Tauchmanova L, Di Somma C, Musella T, Rota F, Savanelli MC, et al. Somatopause: dismetabolic and bone effects. Journal of Endocrinological Investigation 2005;28(10 Suppl):36–42.PubMedGoogle Scholar
  149. 149.
    Liu H, Bravata DM, Olkin I, Nayak S, Roberts B, Garber AM, et al. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Annals of Internal Medicine 2007;146(2):104–15.PubMedGoogle Scholar
  150. 150.
    Gotherstrom G, Bengtsson B-A, Sunnerhagen KS, Johannsson G, Svensson J. The effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients. Clinical Endocrinology 2005;62(1):105–13.PubMedGoogle Scholar
  151. 151.
    Arwert LI, Veltman DJ, Deijen JB, Lammertsma AA, Jonker C, Drent ML. Memory performance and the growth hormone/insulin-like growth factor axis in elderly: a positron emission tomography study. Neuroendocrinology 2005;81(1):31–40.PubMedGoogle Scholar
  152. 152.
    Arwert LI, Veltman DJ, Deijen JB, van Dam PS, Drent ML. Effects of growth hormone substitution therapy on cognitive functioning in growth hormone deficient patients: a functional MRI study. Neuroendocrinology 2006;83(1):12–9.PubMedGoogle Scholar
  153. 153.
    Arwert LI, Deijen JB, Drent ML. The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis. Growth Hormone & Igf Research 2005;15(6):416–22.Google Scholar
  154. 154.
    Kok P, Roelfsema F, Frolich M, Meinders AE, Pijl H. Prolactin release is enhanced in proportion to excess visceral fat in obese women. Journal of Clinical Endocrinology & Metabolism 2004;89(9):4445–9.Google Scholar
  155. 155.
    Tuzcu A, Bahceci M, Dursun M, Turgut C, Bahceci S. Insulin sensitivity and hyperprolactinemia. Journal of Endocrinological Investigation 2003;26(4):341–6.PubMedGoogle Scholar
  156. 156.
    Nilsson L, Binart N, Bohlooly Y M, Bramnert M, Egecioglu E, Kindblom J, et al. Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue. Biochemical & Biophysical Research Communications 2005;331(4):1120–6.Google Scholar
  157. 157.
    Asai-Sato M, Okamoto M, Endo M, Yoshida H, Murase M, Ikeda M, et al. Hypoadiponectinemia in lean lactating women: Prolactin inhibits adiponectin secretion from human adipocytes. Endocrine Journal 2006;53(4):555–62.PubMedGoogle Scholar
  158. 158.
    Wallaschofski H, Kobsar A, Sokolova O, Siegemund A, Stepan H, Faber R, et al. Differences in platelet activation by prolactin and leptin. Hormone & Metabolic Research 2004;36(7):453–7.Google Scholar
  159. 159.
    Serri O, Li L, Mamputu J-C, Beauchamp M-C, Maingrette F, Renier G. The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy. Clinical Endocrinology 2006;64(4):366–70.PubMedGoogle Scholar
  160. 160.
    Kok P, Roelfsema F, Langendonk JG, de Wit CC, Frolich M, Burggraaf J, et al. Increased circadian prolactin release is blunted after body weight loss in obese premenopausal women. American Journal of Physiology - Endocrinology á Metabolism 2006;290(2):E218–24.Google Scholar
  161. 161.
    Galluzzi F, Salti R, Stagi S, La Cauza F, Chiarelli F. Reversible weight gain and prolactin levels—long-term follow-up in childhood. Journal of Pediatric Endocrinology 2005;18(9):921–4.Google Scholar
  162. 162.
    van den Beld AW, Visser TJ, Feelders RA, Grobbee DE, Lamberts SWJ. Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. [see comment]. Journal of Clinical Endocrinology & Metabolism 2005;90(12):6403–9.Google Scholar
  163. 166.
    Katz R, Wong ND, Kronmal R, Takasu J, Shavelle DM, Probstfield JL, et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation 2006;113(17):2113–9.PubMedGoogle Scholar
  164. 167.
    Purnell JQ, Brandon DD, Isabelle LM, Loriaux DL, Samuels MH. Association of 24-hour cortisol production rates, cortisol-binding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women. Journal of Clinical Endocrinology & Metabolism 2004;89(1):281–7.Google Scholar
  165. 168.
    Walker BR. Cortisol—cause and cure for metabolic syndrome? Diabetic Medicine 2006;23(12):1281–8.PubMedGoogle Scholar
  166. 169.
    Chiodini I, Adda G, Scillitani A, Coletti F, Morelli V, Di Lembo S, et al. Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications. Diabetes Care 2007;30(1):83–8.PubMedGoogle Scholar
  167. 170.
    Fiocco AJ, Wan N, Weekes N, Pim H, Lupien SJ. Diurnal cycle of salivary cortisol in older adult men and women with subjective complaints of memory deficits and/or depressive symptoms: relation to cognitive functioning. Stress 2006;9(3):143–52.PubMedCrossRefGoogle Scholar
  168. 171.
    Csernansky JG, Dong H, Fagan AM, Wang L, Xiong C, Holtzman DM, et al. Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. American Journal of Psychiatry 2006;163(12):2164–9.PubMedGoogle Scholar
  169. 172.
    Tomlinson JW, Sherlock M, Hughes B, Hughes SV, Kilvington F, Bartlett W, et al. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis. Journal of Clinical Endocrinology & Metabolism 2007;92(3):857–64.Google Scholar
  170. 173.
    Walker BR. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning. Proceedings of the Nutrition Society 2007;66(1):1–8.PubMedGoogle Scholar
  171. 174.
    Brach JS, Simonsick EM, Kritchevsky S, Yaffe K, Newman AB, Health AaBCSRG. The association between physical function and lifestyle activity and exercise in the health, aging and body composition study. Journal of the American Geriatrics Society 2004;52(4):502–9.PubMedGoogle Scholar
  172. 175.
    Di Francesco V, Zamboni M, Zoico E, Bortolani A, Maggi S, Bissoli L, et al. Relationships between leisure-time physical activity, obesity and disability in elderly men. Aging-Clinical & Experimental Research 2005;17(3):201–6.Google Scholar
  173. 176.
    Rimbert V, Montaurier C, Bedu M, Boirie Y, Morio B. Behavioral and physiological regulation of body fatness: a cross-sectional study in elderly men. International Journal of Obesity 2006;30(2):322–30.PubMedGoogle Scholar
  174. 177.
    Raguso CA, Kyle U, Kossovsky MP, Roynette C, Paoloni-Giacobino A, Hans D, et al. A 3-year longitudinal study on body composition changes in the elderly: role of physical exercise. Clinical Nutrition 2006;25(4):573–80.PubMedGoogle Scholar
  175. 178.
    Kim HJ, Lee JS, Kim CK. Effect of exercise training on muscle glucose transporter 4 protein and intramuscular lipid content in elderly men with impaired glucose tolerance. European Journal of Applied Physiology 2004;93(3):353–8.PubMedGoogle Scholar
  176. 179.
    Fatouros IG, Kambas A, Katrabasas I, Leontsini D, Chatzinikolaou A, Jamurtas AZ, et al. Resistance training and detraining effects on flexibility performance in the elderly are intensity-dependent. Journal of Strength & Conditioning Research 2006;20(3):634–42.Google Scholar
  177. 180.
    Bautmans I, Njemini R, Vasseur S, Chabert H, Moens L, Demanet C, et al. Biochemical changes in response to intensive resistance exercise training in the elderly. Gerontology 2005;51(4):253–65.PubMedGoogle Scholar
  178. 181.
    Vincent HK, Bourguignon C, Vincent KR. Resistance training lowers exercise-induced oxidative stress and homocysteine levels in overweight and obese older adults. Obesity 2006;14(11):1921–30.PubMedGoogle Scholar
  179. 182.
    Villareal DT, Miller BV, 3rd, Banks M, Fontana L, Sinacore DR, Klein S. Effect of lifestyle intervention on metabolic coronary heart disease risk factors in obese older adults. [see comment]. American Journal of Clinical Nutrition 2006;84(6):1317–23.PubMedGoogle Scholar
  180. 183.
    Tsuzuku S, Kajioka T, Endo H, Abbott RD, Curb JD, Yano K. Favorable effects of non-instrumental resistance training on fat distribution and metabolic profiles in healthy elderly people. European Journal of Applied Physiology 2007;99(5):549–55.PubMedGoogle Scholar
  181. 184.
    Verney J, Kadi F, Saafi MA, Piehl-Aulin K, Denis C. Combined lower body endurance and upper body resistance training improves performance and health parameters in healthy active elderly. European Journal of Applied Physiology 2006;97(3):288–97.PubMedGoogle Scholar
  182. 185.
    Villareal DT, Banks M, Sinacore DR, Siener C, Klein S. Effect of weight loss and exercise on frailty in obese older adults. Archives of Internal Medicine 2006;166(8):860–6.PubMedGoogle Scholar
  183. 186.
    Weiss EP, Racette SB, Villareal DT, Fontana L, Steger-May K, Schechtman KB, et al. Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. American Journal of Clinical Nutrition 2006;84(5):1033–42.PubMedGoogle Scholar
  184. 187.
    Thomas GN, Hong AWL, Tomlinson B, Lau E, Lam CWK, Sanderson JE, et al. Effects of Tai Chi and resistance training on cardiovascular risk factors in elderly Chinese subjects: a 12-month longitudinal, randomized, controlled intervention study. Clinical Endocrinology 2005;63(6):663–9.PubMedGoogle Scholar
  185. 188.
    Coker RH, Hays NP, Williams RH, Brown AD, Freeling SA, Kortebein PM, et al. Exercise-induced changes in insulin action and glycogen metabolism in elderly adults. Medicine & Science in Sports & Exercise 2006;38(3):433–8.Google Scholar
  186. 189.
    Binder EF, Yarasheski KE, Steger-May K, Sinacore DR, Brown M, Schechtman KB, et al. Effects of progressive resistance training on body composition in frail older adults: results of a randomized, controlled trial. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2005;60(11):1425–31.Google Scholar
  187. 190.
    Evans EM, Racette SB, Peterson LR, Villareal DT, Greiwe JS, Holloszy JO. Aerobic power and insulin action improve in response to endurance exercise training in healthy 77–87 yr olds. Journal of Applied Physiology 2005;98(1):40–5.PubMedGoogle Scholar
  188. 191.
    Toraman NF, Ayceman N. Effects of six weeks of detraining on retention of functional fitness of old people after nine weeks of multicomponent training. British Journal of Sports Medicine 2005;39(8):565–8; discussion 568.PubMedGoogle Scholar
  189. 192.
    Tsourlou T, Benik A, Dipla K, Zafeiridis A, Kellis S. The effects of a twenty-fourweek aquatic training program on muscular strength performance in healthy elderly women. Journal of Strength & Conditioning Research 2006;20(4):811–8.Google Scholar
  190. 193.
    Berke EM, Koepsell TD, Moudon AV, Hoskins RE, Larson EB. Association of the built environment with physical activity and obesity in older persons. American Journal of Public Health 2007;97(3):486–92.PubMedGoogle Scholar
  191. 194.
    Mazzali G, Di Francesco V, Zoico E, Fantin F, Zamboni G, Benati C, et al. Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: effect of moderate weight loss in older women. American Journal of Clinical Nutrition 2006;84(5):1193–9.PubMedGoogle Scholar
  192. 195.
    Wannamethee SG, Shaper AG, Whincup PH. Modifiable lifestyle factors and the metabolic syndrome in older men: Effects of lifestyle changes. Journal of the American Geriatrics Society 2006;54(12):1909–14.PubMedGoogle Scholar
  193. 196.
    Newman AB, Lee JS, Visser M, Goodpaster BH, Kritchevsky SB, Tylavsky FA, et al. Weight change and the conservation of lean mass in old age: the Health, Aging and Body Composition Study. American Journal of Clinical Nutrition 2005;82(4):872–8; quiz 915–6.PubMedGoogle Scholar
  194. 197.
    van Strien T, van de Laar FA, van Leeuwe JFJ, Lucassen PLBJ, van den Hoogen HJM, Rutten GEHM, et al. The dieting dilemma in patients with newly diagnosed type 2 diabetes: does dietary restraint predict weight gain 4 years after diagnosis? Health Psychology 2007;26(1):105–12.PubMedGoogle Scholar
  195. 198.
    Rideout CA, Linden W, Barr SI. High cognitive dietary restraint is associated with increased cortisol excretion in postmenopausal women. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2006;61(6):628–33.Google Scholar
  196. 199.
    Phillips SM, Hartman JW, Wilkinson SB. Dietary protein to support anabolism with resistance exercise in young men. Journal of the American College of Nutrition 2005;24(2):134S-139S.PubMedGoogle Scholar
  197. 200.
    Evans WJ. Protein nutrition, exercise and aging. Journal of the American College of Nutrition 2004;23(6 Suppl):601S-609S.PubMedGoogle Scholar
  198. 201.
    Guillet C, Zangarelli A, Gachon P, Morio B, Giraudet C, Rousset P, et al. Whole body protein breakdown is less inhibited by insulin, but still responsive to amino acid, in nondiabetic elderly subjects. Journal of Clinical Endocrinology á Metabolism 2004;89(12):6017–24.Google Scholar
  199. 202.
    Flakoll P, Sharp R, Baier S, Levenhagen D, Carr C, Nissen S. Effect of betahydroxy- beta-methylbutyrate, arginine, and lysine supplementation on strength, functionality, body composition, and protein metabolism in elderly women. Nutrition 2004;20(5):445–51.PubMedGoogle Scholar
  200. 203.
    Tidermark J, Ponzer S, Carlsson P, Soderqvist A, Brismar K, Tengstrand B, et al. Effects of protein-rich supplementation and nandrolone in lean elderly women with femoral neck fractures. Clinical Nutrition 2004;23(4):587–96.PubMedGoogle Scholar
  201. 204.
    Bartali B, Semba RD, Frongillo EA, Varadhan R, Ricks MO, Blaum CS, et al. Low micronutrient levels as a predictor of incident disability in older women. Archives of Internal Medicine 2006;166(21):2335–40.PubMedGoogle Scholar
  202. 205.
    Hofbauer KG, Nicholson JR, Boss O. The obesity epidemic: current and future pharmacological treatments. Annual Review of Pharmacology & Toxicology 2007;47:565–92.Google Scholar
  203. 206.
    Carter CS, Onder G, Kritchevsky SB, Pahor M. Angiotensin-converting enzyme inhibition intervention in elderly persons: effects on body composition and physical performance. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2005;60(11):1437–46.Google Scholar
  204. 207.
    Cesari M, Kritchevsky SB, Baumgartner RN, Atkinson HH, Penninx BWHJ, Lenchik L, et al. Sarcopenia, obesity, and inflammation—results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. American Journal of Clinical Nutrition 2005;82(2):428–34.PubMedGoogle Scholar
  205. 208.
    Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007;334(7588):299.PubMedGoogle Scholar
  206. 209.
    Richelsen B, Tonstad S, Rossner S, Toubro S, Niskanen L, Madsbad S, et al. Effect of orlistat on weight regain and cardiovascular risk factors following a very-lowenergy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study. Diabetes Care 2007;30(1):27–32.PubMedGoogle Scholar
  207. 210.
    Bougoulia M, Triantos A, Koliakos G. Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese women. Hormones 2006;5(4):259–69.PubMedGoogle Scholar
  208. 211.
    Zelber-Sagi S, Kessler A, Brazowsky E, Webb M, Lurie Y, Santo M, et al. A doubleblind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease. Clinical Gastroenterology & Hepatology 2006;4(5):639–44.Google Scholar
  209. 212.
    Arterburn DE, Crane PK, Veenstra DL. The efficacy and safety of sibutramine for weight loss: a systematic review. Archives of Internal Medicine 2004;164(9):994–1003.PubMedGoogle Scholar
  210. 213.
    Gursoy A, Erdogan MF, Cin MO, Cesur M, Baskal N. Comparison of orlistat and sibutramine in an obesity management program: efficacy, compliance, and weight regain after noncompliance. Eating & Weight Disorders: EWD 2006;11(4):e127–32.Google Scholar
  211. 214.
    Scholze J, Grimm E, Herrmann D, Unger T, Kintscher U. Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study. [see comment]. Circulation 2007;115(15):1991–8.PubMedGoogle Scholar
  212. 215.
    Di Francesco V, Sacco T, Zamboni M, Bissoli L, Zoico E, Mazzali G, et al. Weight loss and quality of life improvement in obese subjects treated with sibutramine: a double-blind randomized multicenter study. Annals of Nutrition & Metabolism 2007;51(1):75–81.Google Scholar
  213. 216.
    Yee BJ, Phillips CL, Banerjee D, Caterson I, Hedner JA, Grunstein RR. The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea. International Journal of Obesity 2007;31(1):161–8.PubMedGoogle Scholar
  214. 217.
    Van Gaal LF, Rissanen AM, Scheen AJ, Ziegler O, Rossner S, Group RI-ES. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. [see comment][erratum appears in Lancet. 2005 Jul 30–Aug 5;366(9483):370]. Lancet 2005;365(9468):1389–97.PubMedGoogle Scholar
  215. 218.
    Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J, Group RI-NAS. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. [see comment][erratum appears in JAMA. 2006 Mar 15;295(11):1252]. JAMA 2006;295(7):761–75.PubMedGoogle Scholar
  216. 219.
    Despres J-P, Golay A, Sjostrom L, Rimonabant in Obesity-Lipids Study G. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. [see comment]. New England Journal of Medicine 2005;353(20):2121–34.PubMedGoogle Scholar
  217. 220.
    Scheen AJ, Finer N, Hollander P, Jensen MD, Van Gaal LF, Group RI-DS. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. [see comment][erratum appears in Lancet. 2006 Nov 11;368(9548):1650]. Lancet 2006;368(9548):1660–72.PubMedGoogle Scholar
  218. 221.
    Yan ZC, Liu DY, Zhang LL, Shen CY, Ma QL, Cao TB, et al. Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta. Biochemical & Biophysical Research Communications 2007;354(2):427–33.Google Scholar
  219. 222.
    Curioni C, Andre C. Rimonabant for overweight or obesity. Cochrane Database of Systematic Reviews 2006(4):CD006162.Google Scholar
  220. 223.
    O’Brien PE, Dixon JB, Laurie C, Skinner S, Proietto J, McNeil J, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. [see comment][summary for patients in Ann Intern Med. 2006 May 2;144(9):I12; PMID: 16670127]. Annals of Internal Medicine 2006;144(9):625–33.PubMedGoogle Scholar
  221. 224.
    Fatima J, Houghton SG, Iqbal CW, Thompson GB, Que FL, Kendrick ML, et al. Bariatric surgery at the extremes of age. Journal of Gastrointestinal Surgery 2006;10(10):1392–6.PubMedGoogle Scholar
  222. 225.
    Taylor CJ, Layani L. Laparoscopic adjustable gastric banding in patients > or=60 years old: is it worthwhile? Obesity Surgery 2006;16(12):1579–83.PubMedGoogle Scholar

Copyright information

© Springer-Verlag and Serdi Éditions 2008

Authors and Affiliations

  • R. L. Kennedy
    • 1
  • U. Malabu
    • 1
  • M. Kazi
    • 1
  • V. Shahsidhar
    • 1
  1. 1.James Cook University School of MedicineQueenslandAustralia

Personalised recommendations